Back to Results

ISpecimen Inc (ISPC)

iSpecimen Inc. is a healthcare technology company listed on NASDAQ as common stock under the ticker ISPC. The company operates iSpecimen Marketplace, an online platform designed to connect life science researchers with hospitals, laboratories, and other organizations that can provide access to human biospecimens, related subjects, and data. Its marketplace includes a range of specimen types, such as biofluids, solid tissue, and hematopoietic stem and immune cells. These offerings support customers including biopharmaceutical companies, in vitro diagnostic companies, and government and academic institutions. Incorporated in 2009, iSpecimen Inc. is headquartered in Woburn, Massachusetts.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-ISPC
$2.86
25.3% Upside
Undervalued
—
—
—
Weak
—
—
—
0.0%
August 17, 2026
-0.3x
4.0x
3.2x
3.334 M
717.029 K
7.1%
100.0%
-40.1
—
58.6%
Send a message
Valuation • Fair Value

iSpecimen Inc (NASDAQ-ISPC) Fair Value by Valuation Model

Compare the primary fair value estimate for iSpecimen Inc (NASDAQ-ISPC) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$2.86

Estimated upside of 25.3% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$3.73

Earnings power value estimate.

Comps Fair Value

$2.69

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for iSpecimen Inc (NASDAQ-ISPC) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for iSpecimen Inc (NASDAQ-ISPC)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.027 M

Current operating scale indicator.

Revenue Forecast

14.238 M

Forward revenue estimate.

EBITDA

-9.68 M

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review iSpecimen Inc (NASDAQ-ISPC) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for iSpecimen Inc (NASDAQ-ISPC)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-7.94

No elevated caution signal from this screen.

Altman Z-Score

-40.1

Lower score that deserves closer risk review.

FCF / Net Income

58.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for iSpecimen Inc (NASDAQ-ISPC). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for iSpecimen Inc (NASDAQ-ISPC)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 17, 2026

Days to Earnings

27

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for iSpecimen Inc (NASDAQ-ISPC), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

iSpecimen Inc (NASDAQ-ISPC) Stock Forecast & Technical Outlook

Review iSpecimen Inc (NASDAQ-ISPC) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for iSpecimen Inc (NASDAQ-ISPC) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for iSpecimen Inc (NASDAQ-ISPC) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for iSpecimen Inc (NASDAQ-ISPC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for iSpecimen Inc (NASDAQ-ISPC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for iSpecimen Inc (NASDAQ-ISPC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for iSpecimen Inc (NASDAQ-ISPC)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, iSpecimen Inc (NASDAQ-ISPC) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

iSpecimen Inc (NASDAQ-ISPC) Stock FAQ

Quick answers about iSpecimen Inc (NASDAQ-ISPC) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$2.86
Estimated upside 25.3%
Valuation Rating
Undervalued
Estimated upside of 25.3%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for iSpecimen Inc (NASDAQ-ISPC) is $2.86. This implies an estimated upside of 25.3% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 25.3% versus the current market price.

An analyst price target for iSpecimen Inc (NASDAQ-ISPC) is not currently available in the latest data file.

The current financial health read for iSpecimen Inc (NASDAQ-ISPC) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for iSpecimen Inc (NASDAQ-ISPC) is August 17, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for iSpecimen Inc (NASDAQ-ISPC) is -0.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for iSpecimen Inc is 3.334 M.

The current enterprise value listed for iSpecimen Inc is 717.029 K. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for iSpecimen Inc is NASDAQ-ISPC, and the stock is listed on NASDAQ.

iSpecimen Inc (NASDAQ-ISPC) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for iSpecimen Inc is 7.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for iSpecimen Inc is 100.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Health Care Technology Stocks on NASDAQ View more

Waystar Holding Corp (WAY) Waystar Holding Corp (WAY)
Heartflow Inc (HTFL) Heartflow Inc (HTFL)
Schrodinger Inc (SDGR) Schrodinger Inc (SDGR)
Certara Inc (CERT) Certara Inc (CERT)
Goodrx Holdings Inc (GDRX) Goodrx Holdings Inc (GDRX)
HealthStream Inc (HSTM) HealthStream Inc (HSTM)
Sophia Genetics SA (SOPH) Sophia Genetics SA (SOPH)
Trubridge Inc (TBRG) Trubridge Inc (TBRG)
Simulations Plus Inc (SLP) Simulations Plus Inc (SLP)
LifeMD Inc (LFMD) LifeMD Inc (LFMD)
LifeMD Inc Preferred Series A (LFMDP) LifeMD Inc Preferred Series A (LFMDP)
Health Catalyst Inc (HCAT) Health Catalyst Inc (HCAT)
OPTIMIZERx Corp (OPRX) OPTIMIZERx Corp (OPRX)
Definitive Healthcare Corp (DH) Definitive Healthcare Corp (DH)
CareCloud Inc (CCLD) CareCloud Inc (CCLD)
DarioHealth Corp (DRIO) DarioHealth Corp (DRIO)
Onemednet Corp (ONMD) Onemednet Corp (ONMD)
ITonic Holdings Ltd (ITOC) ITonic Holdings Ltd (ITOC)
Firefly Neuroscience Inc (AIFF) Firefly Neuroscience Inc (AIFF)
Scienture Holdings Inc (SCNX) Scienture Holdings Inc (SCNX)
BullFrog AI Holdings Inc Unit (BFRG) BullFrog AI Holdings Inc Unit (BFRG)
Aclarion Inc (ACON) Aclarion Inc (ACON)
Vsee Health Inc (VSEE) Vsee Health Inc (VSEE)
Healthcare Triangle Inc (HCTI) Healthcare Triangle Inc (HCTI)